BPA

Biosante Pharma (BPA)

Biosante Pharmaceuticals

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:BPA

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2007/11/01	06:21	Edgar (US Regulatory)	Biosante Pharmaceuticals Inc - Amended Securities Registration (section 12(b)) (8-A12B/A)	AMEX:BPA	Biosante Pharmaceuticals
2007/10/25	00:23	Edgar (US Regulatory)	Biosante Pharmaceuticals Inc - Current report filing (8-K)	AMEX:BPA	Biosante Pharmaceuticals
2007/10/25	00:23	Edgar (US Regulatory)	Biosante Pharmaceuticals Inc - Current report filing	AMEX:BPA	Biosante Pharmaceuticals
2007/10/25	00:23	Edgar (US Regulatory)	Biosante Pharmaceuticals Inc - Current report filing	AMEX:BPA	Biosante Pharmaceuticals
2007/09/25	02:57	PR Newswire (US)	WallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals	AMEX:BPA	Biosante Pharmaceuticals
2007/08/15	05:15	Business Wire	BioSante Pharmaceuticals Reports Second Quarter 2007 Financial Results	AMEX:BPA	Biosante Pharmaceuticals
2007/08/08	21:00	Business Wire	BioSante Pharmaceuticals to Present at Upcoming Conferences	AMEX:BPA	Biosante Pharmaceuticals
2007/07/25	21:00	Business Wire	BioSante Pharmaceuticals Announces Positive Results for its CaP Technology for Use in Aesthetic Medicine	AMEX:BPA	Biosante Pharmaceuticals
2007/07/11	21:00	Business Wire	BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine	AMEX:BPA	Biosante Pharmaceuticals
2007/07/10	20:00	PR Newswire (US)	WallSt.net (www.wallst.net ) Updates the Investment Community Through All-New Interviews with BPA, PPCO and NVAX	AMEX:BPA	Biosante Pharmaceuticals
2007/06/28	20:00	Business Wire	BioSante Pharmaceuticals, Inc. Joins Russell Microcap Index	AMEX:BPA	Biosante Pharmaceuticals
2007/06/19	21:00	Business Wire	BioSante Pharmaceuticals Announces Oral Contraceptive Phase II Study Initiation	AMEX:BPA	Biosante Pharmaceuticals
2007/06/14	21:00	Business Wire	BioSante Pharmaceuticals Completes $18.3 Million Private Placement of Common Stock	AMEX:BPA	Biosante Pharmaceuticals
2007/06/13	21:45	PR Newswire (US)	Bradley Pharmaceuticals Announces Launch of Elestrin(TM)	AMEX:BPA	Biosante Pharmaceuticals
2007/05/30	22:12	Business Wire	BioSante Pharmaceuticals to Present at Upcoming Conferences	AMEX:BPA	Biosante Pharmaceuticals
2007/05/25	22:26	Business Wire	BioSante Pharmaceuticals Announces $16.5 Million Private Placement of Common Stock	AMEX:BPA	Biosante Pharmaceuticals
2007/05/16	21:00	Business Wire	BioSante Pharmaceuticals to Present at Upcoming Conferences	AMEX:BPA	Biosante Pharmaceuticals
2007/05/07	21:00	Business Wire	BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience	AMEX:BPA	Biosante Pharmaceuticals
2007/05/04	21:45	PR Newswire (US)	Bradley Pharmaceuticals to Preview New Products at ACOG Meeting	AMEX:BPA	Biosante Pharmaceuticals
2007/05/02	20:45	Business Wire	BioSante Pharmaceuticals to Present at Upcoming Conferences	AMEX:BPA	Biosante Pharmaceuticals
2007/05/02	06:00	Business Wire	BioSante Pharmaceuticals Reports First Quarter 2007 Financial Results	AMEX:BPA	Biosante Pharmaceuticals
2007/04/11	21:45	PR Newswire (US)	Bradley Pharmaceuticals' Elestrin(TM) Receives New Patent to 2022	AMEX:BPA	Biosante Pharmaceuticals
2007/04/10	21:00	Business Wire	BioSante Pharmaceuticals Announces Issuance of New Patent Covering Elestrin(TM) and LibiGel(R)	AMEX:BPA	Biosante Pharmaceuticals
2007/04/03	03:09	PR Newswire (US)	Dawson James Securities Reiterates Strong Buy Recommendation on Antares Pharma (Amex: AIS) with $4.00 Price Target	AMEX:BPA	Biosante Pharmaceuticals
2007/03/26	20:30	Business Wire	BioSante Pharmaceuticals Receives Milestone Payment from Bradley Pharmaceuticals	AMEX:BPA	Biosante Pharmaceuticals
2007/03/09	06:34	Business Wire	BioSante Pharmaceuticals Reports Net Profit of $2.8 million for 2006 And Investor Conference Call	AMEX:BPA	Biosante Pharmaceuticals
2007/03/08	22:00	Business Wire	BioSante Pharmaceuticals to Present at Upcoming Conferences	AMEX:BPA	Biosante Pharmaceuticals
2007/01/30	22:00	Business Wire	BioSante Pharmaceuticals Announces Positive Bird Flu Results Using Proprietary Vaccine Adjuvant in Pre-Clinical Study	AMEX:BPA	Biosante Pharmaceuticals
2007/01/16	23:00	Business Wire	Stephen M. Simes, President and CEO of BioSante Pharmaceuticals, Inc., Talks to The Wall Street Transcript	AMEX:BPA	Biosante Pharmaceuticals
2006/12/19	21:45	PR Newswire (US)	Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)	AMEX:BPA	Biosante Pharmaceuticals